Blocking a cellular inflammation process could result in effective therapy for pancreatic cancer

Researchers at the Wistar Institute in Philadelphia discovered a new therapeutic target for pancreatic cancer. The team found that defective mitochondria in cancer cells trigger inflammation that the cells need to survive.